Being Alive Newsletter; July 1992
Dr. Robert Schooley and reported by Walt Senterfitt
If one looks at immune-based therapies in this light, there are two general classes of therapy that have been employed. Some have aimed at increasing the anti-HIV humoral or passive immune response, as in the trials of transfusing serum from people at earlier, latent stages of infection into those with advanced disease. In the next six months to a year, I think you will see more efforts to use monoclonal antibodies to accomplish the same thing. The other kind of approach is to try to enhance the cellular immune response. These include the therapeutic vaccine studies and the ex vivo expansion of the killer T-cells, taking them out of the body and cloning or otherwise expanding them and then putting them back in.
920701
BA920707
Copyright © 1992 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/